Clinical Trial Update: Multiple Ascending-Dose Study of EDP 322 in Healthy Adult Volunteers [Phase 1]

View source ↗

Summary

Phase 1 multiple ascending-dose study of the antibiotic candidate EDP 322 in healthy adult volunteers has been completed. The study is sponsored by Enanta Pharm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methicillin-resistant Staphylococcus Aureus Infection
• Skin and Soft Tissue Infection

Drugs mentioned

• EDP 322 (EDP 322)

Snippet

Sponsor: Enanta Pharmaceuticals, Inc | Conditions: MRSA, SSTI | Phase 1 | Status: COMPLETED